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Diffuse large B-cell lymphomas (DLBCLs) are markedly heterogeneous,
and there is increasing evidence that the biological features of these
tumors vary according to the primary site of disease (lymph node or
various extranodal organs). The Waldeyer s ring (WR), a circular band of
mucosa-associated lymphoid tissue composed of the palatine, lingual and




Morphology and pattern of growth
WR versus nodal DLBCL
In conclusion, WR DLBCLs frequently have a partially 
follicular pattern of growth, and a GC-like phenotype. In 
DLBCL patients with no factor of the age-adjusted IPI, 
the tonsillar localization appears to confer a better 
outcome than primary nodal involvement.
By morphology, 55% of WR DLBCLs were classified as centroblastic, 39% as 
centroblastic polymorphous, 3% as immunoblastic, and 3% unclassifiable. 
Among large biopsy specimens (n=79), 18% had a prominent nodular pattern 
consistent with transformed follicular lymphomas, 35% had a minor nodular 
component (<50%) interpreted as follicular colonization and 47% were diffuse. 
The nodular pattern correlated with centroblastic morphology (p=0,0007). 
The study comprised 209 adult patients with de novo DLBCL
presenting in the WR consecutively included in the GELA protocols during
a 10 year period (1993-2004). All patients (M/F ratio: 1,77/1, mean age 59
years) comprising 81% with stages I-II and 19% with stages III-IV disease,
received intent-to-cure anthracyclin-based polychemotherapy.
The 5-years overall survival (OS) and 5-years event-free survival (EFS)
were 74,2 +/- 3,4% and 66,9 +/- 3,6 %, respectively
Morphology and pattern of growth (further defined in a subset of cases
by immunostaining with a follicular dendritic cell (FDC) marker) were
evaluated on the original slides.
A tissue microarray (TMA) representative of 66 cases with available
paraffin bloks was constructed. Immunohistochemistry was performed on
archival unstained paraffin sections and/or on TMA sections, for the
following markers: CD20, CD3, CD5, Bcl-2, Bcl-6, CD10, Mum-1. Individual
markers and differentiation profile (by Hans’ algorithm) were analyzed and
correlated to the clinical features.
FISH was performed on TMA sections with break-apart probes sets to
detect gene rearrangements of BCL2, BCL6 & c-MYC.
Survival and outcome were analyzed in comparison to a matched cohort
of patients with primary nodal DLBCL.
The GC-like profile correlated with absence of bcl-2 expression (p<0,0001) and 
with centroblastic morphology (p=0,04). In multivariate analysis, the GC-like 
phenotype correlated with better OS (p=0.014), and CD10 expression 





n = 79 n = 73
Diffuse (D) 37 (47%) 7/34 (20%) +
Nodular (N) 42 (53%) 28/39 (72%)
D>N 28 (35%) 15/25 (60%) +
N = or >D 14 (18%) 13/14 (93%) ++
FDC staining
DLBCL with follicular colonization
 DLBCL in association with FL
Bcl2 CD10 Bcl6 MUM1 GC/non-GC
Full slide n = 180 n = 160 n = 60 n =75
Non interpretable 32 23 47 30
Contributive 148 (82%) 141 (88%) 13 (23%) 45 (60%) 84
82 pos 56 pos 11 pos 33 pos 56 GC
66 neg 85 neg 2 neg  12 neg 28 non-GC
55% pos 40% pos 85% pos 73% pos 67% GC
TMA n = 66 n = 66 n = 66 n = 66 n = 66
39 pos 33 pos 31 pos 8 pos 39 GC
27 neg 33 neg 35 neg 58 neg 27 non GC
59% pos 50% pos 46% pos 12% pos 59% GC
Full slide + TMA n = 189 n = 178 n = 76 n = 109 n = 136
105 pos 75 pos 40 pos 40 pos 82 GC
84 neg 103 neg 36 neg 69 neg 54 non-GC
56% pos 42% pos 53% pos 37% pos 60% GC
18q21 3q27 8q24
BCL2 BCL6 C-MYC
n 52 52 52
interpretable 42 35 41
colocalized signals 39 26 38
split signals (translocation) 3 9 3
%  rearrangement 7,10% 25,70% 7,30%
FISH results
